PE ratio relative to earnings growth — is the valuation justified?
| Symbol | Company | PEG | P/E | Growth | vs EW |
|---|---|---|---|---|---|
| BSX | Boston Scientific Corporation | 0.32 | 20.5 | 63.3% | -96% |
| RMD | ResMed Inc. | 0.81 | 21.2 | 26.1% | -89% |
| ZTS | Zoetis Inc. | 1.03 | 12.2 | 11.9% | -87% |
| SYK | Stryker Corporation | 2.32 | 34.3 | 14.8% | -69% |
| DXCM | DexCom, Inc. | 3.43 | 35.4 | 10.3% | -55% |